Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Corinne Axelrod, MPH, LAc, Dipl. Ac.
Corinne Axelrod is the vice president of the AAAOM. She is licensed in Maryland and Washington, D.C. and has a part-time practice in Kensington, Md. She can be reached at caxelrod@aaaomonline.org.